Quratis Inc.

₩3,575As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:348080Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR (46.58%)
Div yield —
ROE (69.96%)
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.28)
PE TTM —
TSR TTM (55.37%)
Mkt cap ₩41.93B
ROIC (12.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,527
(1.33%)
(68.78%)
Buy 8|5|1|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
33.05
35.70
34.29
36.33
(0.55%)
8.96%
1.77%
12.70%
Revenue₩B
2.031
2.068
2.122
2.138
5.71%
8.21%
5.24%
2.19%
Peers (US$30.91M)
Cap (US$)
PE
33.07M
7.715x
33.02M
—
Capital
TTM
5Y
10Y
Leveragex
0.837
0.803
0.561
EBIT/Intx
0.531
0.297
0.275
Own earn%
48.23
90.76
78.31
Sh yield%
18.43
37.87
37.39
Owners
Insiders/Inst%
12.27
64.37
Short interest%
3.77
SBC / revenue%
3.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
15–21
$1 testx
0.0
Incr. ROIC%
15